News
At six months pregnant, Sonja Lee Finnegan flew from Switzerland to France to buy $20,000 worth of drugs from a person she had never met. The drug she was after, Trikafta, is legal in Switzerland ...
The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.
The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.
Trikafta, taken as three tablets a day, is the most powerful and widely used of Vertex’s four cystic fibrosis medications.With a list price of over $322,000 annually in the United States, it is ...
Trikafta was approved in the United States in 2019, and it was approved in the European Union in 2020 under the name Kaftrio. ... Israel, Switzerland, the United Kingdom, and Australia.
BOSTON, June 06, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment ...
Hosted on MSN12mon
Vertex (VRTX) NDA for Vanza Triple Therapy Accepted by FDA - MSNThe company’s CF sales continue to grow, driven by its triple therapy, Trikafta (marketed as Kaftrio in Europe). Trikafta/Kaftrio generated revenues of $2.48 billion in the first quarter of 2024 ...
Trikafta’s sticker price is more than $300,000 a year. Insurance typically covers most of that cost—minus what can be significant co-pays and deductibles—and Vertex offers co-pay assistance.
Patients in the Alyftrek groups of both trials also experienced more improved sweat chloride concentrations vs. patients in the Trikafta groups at the 24-week mark (least squares mean treatment ...
Patients, doctors worry "miracle" drug may no longer be available in Colorado 04:24. Some Coloradans are sounding an alarm after learning a state board is considering capping the price of a life ...
Access to Trikafta is now at risk for several hundred people with cystic fibrosis, thanks to what some might consider to be good intentions. Skip to Main Content. FDA. research. weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results